Early access
Sign in
Not yet taking people in United StatesNo phase

Starting HIV medicine quickly for people in the hospital

Looks at starting HIV medicine during hospital stays and linking adults to care.

Key facts

Who runs it
University of Chicago
Where
Chicago, United StatesSee the site
Trial code
Registry title
Building Rapid Inpatient Delivery of ART to Generate Engagement in HIV Care
Status
Not yet recruiting
People taking part
40 people, planned
Starts
Feb 2027
Expected to end
May 2028
Type of study
Observational
Record updated
29 September 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults living with HIV who are in the hospital on certain wards at University of Chicago Medicine and have a detectable viral load.

Age
18 years or older
Sex
All sexes can join.
Disease stage
HIV viral load above 200 copies/mL.
Biomarker or test result
HIV viral load > 200 copies/mL

Main reasons for not taking part

  • Under 18 years of age
  • Not admitted to the UCM General Medicine or Hospital Medicine wards during the study time period
  • Not living with HIV
  • HIV viral load < 200 copies/mL
  • Cannot speak and understand English

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • 18 years of age or older
  • Admitted to the UCM General Medicine or Hospital Medicine wards during the study time period
  • Living with HIV
  • HIV viral load > 200 copies/mL
  • Able to speak and understand English
  • Able and willing to provide informed consent

Who cannot take part

  • Not living with HIV
  • HIV viral load < 200 copies/mL
  • Less than 18 years of age
  • Not admitted to the UCM General Medicine or Hospital Medicine wards during the study time period
  • Not able to speak and understand English
  • Unable and/or unwilling to provide informed consent

Where in United States

  • University of ChicagoChicago, United StatesContact: Jessica P. Ridway, MD, MSNot yet recruiting

About the trial

What the trial wants to find out

The study team will pilot rapid antiretroviral therapy (ART) initiation as part of routine inpatient care at the University of Chicago Medicine (UCM), comparing outcomes over a 12-month implementation period. Electronic medical record (EMR) data will be used to evaluate clinical outcomes such as ART initiation within 24-48 hours, linkage to HIV care, retention, and viral suppression, as well as demographic and clinical factors associated with these outcomes. Implementation outcomes will be assessed using Proctor's framework, including acceptability, feasibility, fidelity, and appropriateness.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Building Rapid Inpatient Delivery of ART to Generate Engagement in HIV Care (BRIDGE)
Plain-language title
Starting HIV medicine quickly for people in the hospitalGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
29 September 2026